Condition
Cancer Cachexia (CC)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07237464Phase 1RecruitingPrimary
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
NCT06737692Not ApplicableNot Yet RecruitingPrimary
Effects of Aerobic and Resistance Exercise Training in Individuals with Cancer Cachexia
NCT06645067Not Yet RecruitingPrimary
Assessment and Modulation of Energy Balance in Cachectic Patients Using Adapted Physical Activity
Showing all 3 trials